The effect of reteplase on the dysfunctional permanent central venous catheter of hemodialysis

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201101049227N1

Enrollment

Registered

2020-11-28

Start date

2020-12-05

Completion date

Unknown

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central venous catheter.

Interventions

Intervention 1: Intervention group: Injection of 2 ml of Reteplase containing 0.4 units of drug. Intervention 2: Control group: Injection of 2 ml of heparin.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Lack of blood flow in catheter lumen ability to aspiration of heparin from lumen flow rate less than 150 ml/min

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Catheter function correction. Timepoint: 30 minutes. Method of measurement: Lumen flow more than 250 ml per minute.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Morteza Hashemizadeh

Zahedan University of Medical Sciences

m.hashemizadeh@zaums.ac.ir+98 54 3329 5570

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026